Malignant Pleural Effusion Secondary to Clear cell Renal Cell Carcinoma- A Case Report
DOI:
https://doi.org/10.56501/intjclinicopatholcorrel.v8i1.1063Keywords:
Renal cell carcinoma, pleural effusion, clear cell carcinoma, metastasesAbstract
Renal cell carcinoma is the most common renal neoplasm. Its presentation is often very occult, and it may be discovered incidentally. It may present with the classic symptoms of back pain, flank pain, hematuria, or hypertension. Renal cell carcinoma may also present with malignant pleural effusion at diagnosis; however, it is very rare. Pleural effusion secondary to renal cell carcinoma constitutes only about 1% to 2% of all malignant pleural effusions. We report a case of 55-year-female who was a known case of Right side Renal cell carcinoma post operated and on chemotherapy suddenly presented in emergency department with breathlessness and chest pain. Chest X-ray demonstrated right-sided moderate pleural effusion; computed tomography (CT) reported bilateral effusion in the pleural cavity. CT-guided pleural thoracocentesis was performed. Cytology and cell block morphology showed clear cell type malignant tumor, leading to diagnosis of clear cell carcinoma in pleural fluid secondary to clear cell renal cell carcinoma. The study aim to discuss the Malignant pleural effusion secondary to Clear cell Renal cell carcinoma.
References
Wasifuddin M, Ilerhunmwuwa N, Hakobyan N, et al. Malignant Pleural Effusion As the Initial Presentation of Renal Cell Carcinoma: A Case Report and Literature Review. Cureus.2023 15(4): e37128. https://doi.org/10.7759/cureus.37128.
Hutchinson A H, Fakhouri E W, Raudales J , Recurrent Large Volume Malignant Pleural Effusion in a Patient With Renal Cell Carcinoma. Cureus.2022; 13(2): e13593. https://doi.org/10.7759/cureus.13593.
Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol. 2005;48(1):77-81. https://doi.org/10.1016/j.eururo.2005.03.004
Eckardt J, Ladegaard L, Licht PB: Isolated pleural metastases from renal cell carcinoma . Interact Cardiovasc Thorac Surg. 2011, 12:301-2. https://doi.org/10.1510/icvts.2010.245340 4.
Schiavoni V, Campagna R, Pozzi V, Cecati M, Milanese G, Sartini D, Salvolini E, Galosi AB, Emanuelli M. Recent advances in the management of clear cell renal cell carcinoma: Novel biomarkers and targeted therapies. Cancers. 2023 Jun 16;15(12):3207. https://doi.org/10.3390/ cancers15123207
Kiely JM. Hypernephroma—the internists tumor. Medical Clinics of North America. 1966 ,50(4):1067-83. https://doi.org/10.1016/s0025-7125(16)33152-2.
Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. Bmj. 349:g4797. https://doi.org/10.1136/bmj.g4797.
Studentova H, Rusarova N, Ondruskova A, Zemankova A, Student Jr V, Skanderova D, Melichar B. The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature. Current Oncology. 2022;29(8):5475-88. https://doi.org/10.3390/curroncol29080433
Shuch B, Zhang J. Genetic predisposition to renal cell carcinoma: implications for counseling, testing, screening, and management. Journal of Clinical Oncology. 2018;36(36):3560-6. https://doi.org/10.1200/JCO.2018.79.2523.
Gerlinger M, Horswell S, Larkin J, Rowan AJ, Salm MP, Varela I, Fisher R, McGranahan N, Matthews N, Santos CR, Martinez P. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nature genetics. 2014;46(3):225-33. https://doi.org/10.1038/ng.2891.
Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022; Jun 20;39(3):1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ashutosh Jha, Meghashree Vishwanath, Prakashiny Sinnarajah, Prathipaa Rajavel, Pavithra Rajasekaran, Ramamoorthy Vedachalam
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.